CELANO MICHAEL (Chief Financial Officer) received a stock award from LARIMAR THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/24/2025ACC: 0001062993-25-001077
Officer· Chief Financial Officer
Since May 2020
+239.30K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
239.30K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+34.19K
Price / share
—
Trade value
—
% of position
23.7%
1/22/2025
144K→178.18K
Total
Net shares
+34.19K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/22/2025 | A · Award | +34.19K | — | — | 23.7% | 144K | 178.18K |
| Total | +34.19K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
205.11K shares
Shares
+205.11K
Strike price
3.46
Held after
205.11K
Exercisable
—
1/22/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock205.11K shares | 1/22/2025 | A · Award | +205.11K | 3.46 | — | 205.11K |